Prof. Tarek Aboul-Fadl has completed his PhD in Medicinal Chemistry from Assiut University, Egypt (1994) under the channel system and joint supervision scheme between Assiut University and Josai University/Japan. He performed his postdoctoral training as a postdoctoral research fellow and scientist of Pharmaceutical and Medicinal Chemistry at University of Vienna, Austria (1997- 1998), Friedrich-Alexander-Universität, Erlangen-Nürnberg, Germany (1999 and 2013) and University of Utah, USA (2001-2002 and 2004-2005). He has over 77 publications and 4 patents that have been cited over 1880 times, and his publication H-index is 23(google_scholar). He awarded ACDIMA Research Award for the Best Scientific Research in Arab World, 2012.
Title : Thiadiazine-2-thione derivatives as new cell- cycle inhibitors
Title : Novel Azine Linked Hybrids of 2-indolinone and Thiazolodinone Scaffolds as CDK2 inhibitors with potential anticancer activity